🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Nanoliposomal Irinotecan

Irinotecan Liposome (II) or Etoposide Combined With Adebrelimab and Carboplatin in the Treatment of ES-SCLC NCT06739928Phase 21 site📍 Guangzhou Guangzhou Institute of Respiratory Disease · Tests: Irinotecan liposome (II) combined with adebrelimab and carboplatin, etoposide combined with adebrelimab and carboplatin Study of NALIRIFOX in Advanced Unresectable Small Bowel Tumors NCT06835387Phase 27 sites📍 Tampa📍 Chicago📍 Fort Wayne Tiago Biachi de Castria · Tests: Nanoliposomal irinotecan, Oxaliplatin, 5 fluorouracil, Leucovorin Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC NCT06657690Phase 21 site📍 Zhuhai Sun Yat-sen University · Tests: Irinotecan liposome, S-1 Evaluation of Irinotecan Liposome (II) Combined With 5-FU, LV, and Bevacizumab for mCRC NCT06643793Phase 21 site📍 Nanjing Affiliated Hospital of Nantong University · Tests: Irinotecan liposome (ll) + 5-FU/LV + bevacizumab Nanoliposomal Irinotecan, Oxaliplatin Plus Capecitabine As Conversion Therapy of Locally Advanced Colorectal Cancer NCT06405139Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Nanoliposomal Irinotecan, Oxaliplatin plus Capecitabine Liposomal Irinotecan and Leucovorin/5-fluorouracil Plus Bevacizumab in Metastatic Colorectal Cancer NCT06184698Phase 21 site📍 Shijiazhuang Hebei Medical University Fourth Hospital · Tests: liposomal irinotecan, 5-FU, LV, Bevacizumab Treatment of Newly Diagnosed Rhabdomyosarcoma Using Molecular Risk Stratification and Liposomal Irinotecan Based Therapy in Children With Intermediate and High Risk Disease NCT06023641Phase 23 sites📍 Palo Alto📍 Memphis📍 Fort Worth St. Jude Children's Research Hospital · Tests: Vincristine, Dactinomycin, Cyclophosphamide, Surgical Resection, Proton beam radiation or external beam radiation or br… Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer . NCT05927857Phase 1, Phase 21 site📍 Taipei National Health Research Institutes, Taiwan · Tests: nal-IRI /Experimental, Ramucirumab /Experimental, Trifluridine/Tipiracil /Experimental New Second-Line Combo Therapy for MSS Metastatic Colorectal Cancer NCT07559760Phase 21 site📍 Changchun The First Hospital of Jilin University · Tests: Levofolinic Acid + 5-FU continuous infusion + irinotecan HCl liposome ± cetuximab/bevacizumab Oxaliplatin and Liposomal Irinotecan (Plus Trastuzumab for HER2-positive Disease) in Advanced Esophageal and Gastric Adenocarcinoma NCT04150640Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: Nal-IRI, Oxaliplatin, 5-FU, Trastuzumab, Pembrolizumab Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treatment of Advanced Colorectal Cancer: A Single-arm, Phase II Clinical Study NCT07047560Phase 21 site📍 Tianjin Tianjin Medical University Cancer Institute and Hospital · Tests: fractionated liposomal irinotecan (II)-based combination chemotherapy (FOLFIRInali-3) plus bevacizumab (Bev) Irinotecan Liposome Combined With Oxaliplatin and Tegafur as Adjuvant Therapy for Pancreatic Cancer NCT06361316NA1 site📍 Nanjing Kuirong Jiang · Tests: Irinotecan liposome injection Stereotactic Body Radiotherapy and NALIRIFOX for Locally Advanced Pancreatic Cancer NCT07173387Phase 21 site📍 Jinan Shandong Cancer Hospital and Institute · Tests: NALIRIFOX (liposomal irinotecan-based chemotherapy)., Stereotactic Body Radiation Therapy (SBRT). Phase II Study of Irinotecan Liposome (II) Combined With Temozolomide and Fluzoparib in Recurrent or Metastatic Ewing Sarcoma NCT06827717Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: irinotecan liposome (II) + temozolomide + fluzoparib Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma NCT07479732Phase 1, Phase 21 site📍 Beijing Peking University People's Hospital · Tests: Liposomal Irinotecan, Apatinib in arm1 Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil for Advanced Cholangiocarcinoma NCT06438822Phase 21 site📍 Chengdu West China Hospital · Tests: Cadonilimab Combined With Liposomal Irinotecan Plus Leucovorin and Fluorouracil Liposomal Irinotecan + Oxaliplatin + Bevacizumab Versus Liposomal Irinotecan + 5-FU/LV NCT06782685Phase 1, Phase 22 sites📍 Beijing📍 Beijing Dai, Guanghai · Tests: Irinotecan liposoma, oxaliplatin, bevacizumab, 5-FU, LV Clinical Study of Second-line Treatment in Advanced Colorectal Cancer With Chemotherapy With Bevacizumab or Cetuximab NCT06540326Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: irinotecan liposome (II), fluorouracil, cetuximab, bevacizumab, Capecitabine Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases NCT07504471Phase 21 site📍 Shanghai Ruijin Hospital · Tests: pH-NASOX-Immune Group NALIRI-XELOX+AK104 for First-line Treatment of Advanced PDAC NCT06405490Phase 21 site📍 Beijing Cancer Institute and Hospital, Chinese Academy of Medical S… · Tests: Nanoliposomal Irinotecan+Oxaliplatin +Capecitabine+Cadonilimab Combination Therapy for PD-1 Resistant Recurrent or Metastatic Nasopharyngeal Carcinoma: A Bayesian Adaptive Phase II Trial NCT07070479Phase 26 sites📍 Guangzhou📍 Guangzhou📍 Guangzhou Ming-Yuan Chen · Tests: Ivonescimab, Nimotuzumab, Irinotecan liposome, S-1, Mitoxantrone Hydrochloride Liposome Resection/Synchronous Pulmonary or Hepatic Oligometastatic Pancreatic Ductal Adenocarcinoma NCT07340151NA1 site📍 San Antonio The University of Texas Health Science Center at San Antonio · Tests: Surgical resection NALIRIFOX (Nal-IRI Plus 5-FU/LV Plus Oxaliplatin) as First-Line Treatment for Patients With Advanced Small Intestine and Appendiceal Cancers NCT07060014Phase 12 sites📍 Houston📍 Houston The Methodist Hospital Research Institute · Tests: Patients will be treated with NALIRIFOX (liposomal irinotecan 50 mg/m2 + 5-FU 2400 mg/m2 + LV 400 mg/m2 + oxaliplatin 6… Irinotecan Liposome in Combination With Capecitabine NCT06578052NA1 site📍 Shenzhen Junjie Hang · Tests: Irinotecan liposome Capecitabine Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer. NCT07044921Phase 21 site📍 Beijing Chinese PLA General Hospital · Tests: Irinotecan Liposomes (II)+Cetuximab+Bevacizumabl Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer NCT05854498Phase 21 site📍 Madison University of Wisconsin, Madison · Tests: Liposomal irinotecan, TAS102, Bevacizumab Sintilimab Plus NALIRIFOX or Gemcitabine-Cisplatin as First-Line Treatment for Metastatic Biliary Tract Cancer NCT07831993Phase 21 site📍 Nanjing The Affiliated Nanjing Drum Tower Hospital of Nanjing Unive… · Tests: Sintilimab, Irinotecan Hydrochloride Liposome Injection (II), Oxaliplatin, Leucovorin, Fluorouracil SCRT-NALIRIXELOX+Sintilimab as TNT for High-Risk LARC NCT07474103NA1 site📍 Wuhan Union Hospital, Tongji Medical College, Huazhong University… · Tests: SCRT, Liposomal Irinotecan, Oxaliplatin, Capecitabine, Sintilimab Liposomal Irinotecan and Apatinib in ES-SCLC NCT06749691Phase 21 site📍 Hangzhou Second Affiliated Hospital, Zhejiang University, School of … · Tests: Liposomal Irinotecan and Apatinib Intraperitoneal Injection of Liposomal Irinotecan as Monotherapy or in Combination With Recombinant Mutant Human Tumor Necrosis Factor or Bevacizumab for the Treatment of Malignant Ascites Following Failure of Prior Standard Therapy NCT07397819Phase 1, Phase 21 site📍 Guangzhou Dong sheng Zhang · Tests: liposomal irinotecan monotherapy, liposomal irinotecan monotherapy, Liposomal Irinotecan + rmhTNF-NC, Liposomal Irinote…
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy